Skip to content

Effects of Balloon Blowing Therapy and Bubble PEP on Oxygen Saturation, Dyspnea, and Enjoyment in Pediatric Pneumonia

Comparative Effects of Balloon Blowing Therapy and Bubble PEP on Oxygen Saturation, Dyspnea, and Perceived Enjoyment in Children With Pneumonia

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07578870
Enrollment
40
Registered
2026-05-11
Start date
2026-04-14
Completion date
2026-06-05
Last updated
2026-05-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pneumonia in Children

Keywords

Pneumonia, Balloon Blowing Therapy, Bubble PEP, Oxygen saturation

Brief summary

Pneumonia is a major cause of illness and death in children, leading to breathing difficulties and reduced oxygen levels due to impaired gas exchange. Non-pharmacological techniques like balloon blowing and Bubble PEP are simple, engaging methods used to improve respiratory function. This randomized clinical trial will compare the effects of Balloon Blowing Therapy and Bubble PEP on oxygen saturation, dyspnea, and enjoyment in 40 children with pediatric pneumonia over one week.

Detailed description

Pneumonia is one of the main causes of morbidity and mortality in children worldwide and serious pediatric health concern. Symptoms including hypoxia, tachypnea, and dyspnea are brought on by inflammation and fluid buildup in the alveoli, which hinders gas exchange.Supportive oxygen therapy and antibiotics are usually used in conventional treatment, nonpharmacological therapies have become more prevalent to improve respiratory outcomes.Breathing techniques, such as bubble positive expiratory pressure (PEP) therapy and balloon blowing, are being used extensively to assist gas exchange, enhance lung function, and encourage airway clearing. These techniques are useful in children because these are easy to use, entertaining, and cost-effective. This randomized clinical trial aims to compare the effects of Balloon Blowing Therapy (BBTG) and Bubble PEP Therapy (BPTG) on oxygen saturation, dyspnea, and perceived enjoyment in children with Pneumonia. Forty children aged 6-12 years diagnosed with pneumonia, fulfilling the eligibility criteria will be recruited through non-probability purposive sampling. Participants will be randomly assigned to two groups. Group A will receive Balloon Blowing Therapy along with baseline breathing techniques. Group B will receive Bubble PEP Therapy with the same baseline breathing techniques. Interventions will be administered twice daily in 5 consecutive days for 1 week. Outcome measures include oxygen saturation assessed via pulse oximeter, dyspnea assessed via Modified Borg Dyspnea Scale, and perceived enjoyment measured by a 5-point smiley Likert scale. Data will be analyzed using SPSS software.

Interventions

DEVICEBalloon Blowing Therapy

Balloon Blowing Therapy involves deep breathing followed by exhaling into a balloon to create positive pressure, improving lung expansion and airway clearance. It is combined with diaphragmatic and pursed-lip breathing, performed twice daily in 5 days for 1 week

Bubble PEP involves deep inhalation followed by exhalation through water to create resistance and positive pressure, improving lung expansion and airway clearance. It is combined with diaphragmatic and pursed-lip breathing, performed twice in 5 days for 1 week

Sponsors

Riphah International University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
OTHER
Masking
SINGLE (Subject)

Masking description

Participants will get separate treatment protocols and possible efforts will be put to mask both groups about treatment

Intervention model description

Randomized Clinical Trial (RCT), this study will include 40 pediatric participants age 6 -12 years, recruited from Gulab Devi Chest Hospital LHR. Participants will be randomly divided into 2 groups: one receiving Ballon Blowing Therapy with baseline breathing exercises and other group receive Bubble PEP with baseline breathing exercises. Outcome measures, including oxygen saturation (via Pulse Oximeter ), dypnea ( via Modified Borg Dyspnea Scale), and perceived enjoyment ( via 5-point Likert scale with faces or smiley icons ) will be recorded pre- and post- intervention. Statistical analysis will be performed using SPSS version 2023 to determine the intervention's effects.

Eligibility

Sex/Gender
ALL
Age
6 Years to 12 Years
Healthy volunteers
No

Inclusion criteria

* Children aged 6 to 12 years * Medically stable and cleared to perform breathing exercises * Both genders will be included * Presence of dyspnea according to the patient's statement * Peripheral oxygen saturation (SpO2) \<94%

Exclusion criteria

* Children who are critically ill patients on bi-pep or a ventilator, as well as patients who were intubated and uncooperative * Children with any oral surgery * Participants were excluded from the study, if they had any contraindication to the use PEP therapy (severe haemoptysis) * Refusal to participate or inability to complete full sessions

Design outcomes

Primary

MeasureTime frameDescription
Pulse oximeter1 weekOxygen saturation measured using a pulse oximeter to assess oxygen saturation in children with pneumonia.In healthy children, normal oxygen saturation (SpO₂) typically ranges from 95% to 100%, while values ≤92% indicate significant hypoxemia requiring medical attention.
Modified Borg Dyspnea Scale1 weekIt is a patient-reported numerical scale assessing breathlessness during activity, ranging from 0 to 10, where 0 indicates no breathlessness and 10 indicates maximal breathlessness. Higher scores represent greater dyspnea.
5-point Likert Scale with Faces1 weekThis 5-point Likert scale with faces measures children's enjoyment and engagement during therapy. Scores range from 1 (not enjoyable) to 5 (highly enjoyable), with higher scores indicating greater enjoyment.

Countries

Pakistan

Contacts

CONTACTImran Amjad, Phd
imran.amjad@riphah.edu.pk923224390125
CONTACTMuhammad Asif Javed, MS-PT
a.javed@riphah.edu.pk923224209422
PRINCIPAL_INVESTIGATORMahnoor ikram, MS-PT

Riphah International University

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: May 12, 2026